Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5030 total record number 58 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 7 out of 35
341 citations found

Human NLRP1 is a sensor for double-stranded RNA

Bauernfried, S;Scherr, MJ;Pichlmair, A;Duderstadt, KE;Hornung, V;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

A comprehensive guide to studying inflammasome activation and cell death

Tweedell, RE;Malireddi, RKS;Kanneganti, TD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

A serological survey of Bacillus anthracis reveals widespread exposure to the pathogen in free-range and captive lions in Zimbabwe

Mukarati, NL;Ndumnego, OC;Ochai, SO;Jauro, S;Loveridge, A;van Heerden, H;Matope, G;Caron, A;Hanyire, TG;de Garine-Wichatitsky, M;Pfukenyi, DM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation

Magupalli, VG;Negro, R;Tian, Y;Hauenstein, AV;Di Caprio, G;Skillern, W;Deng, Q;Orning, P;Alam, HB;Maliga, Z;Sharif, H;Hu, JJ;Evavold, CL;Kagan, JC;Schmidt, FI;Fitzgerald, KA;Kirchhausen, T;Li, Y;Wu, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Anthrax toxin component, Protective Antigen, protects insects from bacterial infections

Alameh, S;Bartolo, G;O'Brien, S;Henderson, EA;Gonzalez, LO;Hartmann, S;Klimko, CP;Shoe, JL;Cote, CK;Grill, LK;Levitin, A;Martchenko Shilman, M;

Product: Anthrax Edema Factor (EF), Recombinant from B. anthracis

Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes

Patel, VI;Booth, JL;Dozmorov, M;Brown, BR;Metcalf, JP;

Product: Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

  • Protective Antigen Binding Assays

    For all PA binding assays, activated PA (63 kDa, List Biological Laboratories, Inc.; Campbell, CA, USA) was labeled using an Alexa Fluor® 647 Microscale Protein Labeling Kit (Molecular Probes; Waltham, MA, USA) following the manufacturer’s instructions. RAW 264.7, human BAL cells, and human leukocytes were processed as described for anthrax surface receptor expression through the point of Fc receptor blocking. At this point, cells were either left untreated, or incubated with 3000 or 10,000 ng/mL unlabeled PA as indicated for 30 min on ice. Cells were then exposed to AF647-labeled PA at 10, 100, or 1000 ng/mL for an additional 30 min on ice. In the case of lung and blood cells, antibodies used for cell subset-specific identification were also added at the same time as AF647-PA. All samples were centrifuged at 300× g for 5 min and washed twice with 1X PBS-2. Samples were fixed with 2% paraformaldehyde prior to flow cytometry.

    Product #174 – Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Toxin Neutralization Assay (TNA)
    The functional ability of antibodies from vaccinated cattle and controls to neutralize anthrax lethal toxin was assessed using an in vitro TNA, as previously described by Ndumnego et al. [16]. The TNA was determined with J774A.1 mouse macrophage cells (ECACC cat no 91051511) exposed to anthrax lethal toxin in the presence of antibodies. Briefly, 1.0 × 105 J774A.1 macrophages per well in Dulbecco’s Modified Eagle Media (DMEM) and 10% foetal bovine serum (FBS) were incubated at 37 °C and 5% CO2 overnight in 96-well cell culture plates. Sera from each animal were 2-fold serially diluted in duplicates with the starting dilution of 1:50 in DMEM formulated with 5% FBS containing PA (500 ng/mL) and LF (400 ng/mL) (List Biological Laboratories Inc, Campbell, CA, USA) for 1 h at 37 °C and 5% CO2 before addition to the overnight-cultured confluent J774A. …

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis
    Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores

Benn Felix, J;Chaki, SP;Xu, Y;Ficht, TA;Rice-Ficht, AC;Cook, WE;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Detection of anthrax-specific antibody levels

    Anthrax-specific antibody levels against protective antigen were measured by ELISA12. High binding ELISA plates were coated with 100 ng per well of anthrax protective antigen (List Biological Laboratories Inc., Campbell, CA, USA) in carbonate buffer, pH 9.6 and incubated at 37 °C for 1 h, then overnight at 4 °C. …

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis